Mohammad Almalla, MD

Original Contribution

Protected Percutaneous Coronary Intervention of Unprotected Left Main Using Impella Ventricular Assist Device Before Transcatheter Aortic Valve Implantation: A Single-Center Experience

03/01/2022

Timothee Noterdaeme , MD;

Jörg Schröder , MD;

Ertunc Altiok , MD;

Nikolaus Marx , MD;

Mohammad Almalla , MD;

Kinan Kneizeh , MD;

Anas Alnaimi , MD;

Transcatheter aortic valve implantation (TAVI) is nowadays the optimal therapeutic strategy in patients with severe aortic valve stenosis (AS). Consequently, percutaneous coronary intervention (PCI) of concomitant complex coronary artery...

Transcatheter aortic valve...

03/01/2022

Journal of Invasive Cardiology

Original Contribution

Long-Term Clinical Outcome of Sirolimus-Eluting Stent Implantation in Metabolic Syndrome and Diabetes

07/06/2010

Karl-Christian Koch , MD;

Jörg Schröder , MD;

Nikolaus Marx , MD;

Mohammad Almalla , MD;

Rainer Hoffmann , MD;

Verena Deserno , MS;

Felix Vogt , MD;

Ralf Koos , MD;

ABSTRACT: Background. Patients with metabolic syndrome (MetS) are at increased risk of cardiovascular events. The long-term effectiveness of sirolimus-eluting stents (SES) in patients with MetS and in diabetic patients is not well defined....

ABSTRACT: Background....

07/06/2010

Journal of Invasive Cardiology